Vistagen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

0.5300

+0.0244 (4.83%)

At close: Feb 17, 2026, 4:00 PM EST

0.5474

+0.0174 (3.28%)

Pre-market: Feb 18, 2026, 4:29 AM EST

Vistagen Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 17, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	21	72	143	27	256	305
Market Cap Growth	-73.91%	-49.43%	421.73%	-89.32%	-16.12%	1309.99%
Enterprise Value	-39	-15	18	5	176	211
Last Close Price	0.53	2.50	5.28	3.74	37.20	63.90
PS Ratio	23.77	148.47	134.11	-120.48	230.95	280.23
PB Ratio	0.41	1.02	1.25	2.26	3.96	3.11
P/TBV Ratio	0.41	1.02	1.25	2.26	3.96	3.32
EV/Sales Ratio	-	-	17.28	-	158.30	193.50
Debt / Equity Ratio	0.03	0.02	0.02	0.22	0.05	0.04
Net Debt / Equity Ratio	-1.18	-1.12	-1.02	-1.15	-1.01	-1.01
Net Debt / EBITDA Ratio	0.87	1.42	3.56	0.24	1.37	5.58
Net Debt / FCF Ratio	1.00	1.87	4.52	0.28	1.43	8.05
Asset Turnover	0.01	0.01	0.02	-	0.01	0.02
Quick Ratio	4.57	6.38	23.26	3.64	11.88	24.62
Current Ratio	4.68	6.51	23.56	3.83	12.32	24.86
Return on Equity (ROE)	-101.55%	-55.68%	-46.47%	-154.30%	-58.62%	-36.78%
Return on Assets (ROA)	-55.53%	-33.64%	-28.52%	-77.39%	-32.65%	-19.66%
Return on Capital Employed (ROCE)	-135.70%	-78.00%	-27.90%	-358.90%	-69.40%	-17.20%
Earnings Yield	-319.29%	-71.26%	-20.58%	-216.63%	-18.65%	-5.87%
FCF Yield	-288.29%	-58.61%	-18.13%	-182.55%	-17.75%	-4.04%
Buyback Yield / Dilution	-15.56%	-59.53%	-178.13%	-5.45%	-129.85%	-96.34%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q